Advances of study on glucocorticoids in the treatment of rheumatoid arthritis

Abstract

Abstract: The glucocorticoids treat on patients with rheumatoid arthritis (RA) had a more than sixty years history, due to glucocorticoids have some side effects, different rheumatologists have different opinions. According to some clinical research for the past few years, glucocorticoids can improve the condition and inhibit the damage of join. This article is a review about the clinical effects and side effects of treatment for RA with glucocorticoids

Key words: Rheumatoid arthritis, Glucocorticoids, Treat

CLC Number:

R593.22

LI Dan-dan, LU Jin-ming. Advances of study on glucocorticoids in the treatment of rheumatoid arthritis[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2012, 17(1): 116-120.

References

[1] 王永福. 糖皮质激素对类风湿关节炎治疗作用的再认识[J]. 中国处方药,2008,7(9):65-67.
[2] Van Everdingen AA, Jacobs JW, Siewertsz Van Reesema DR, et al. Low-dose prednisone therapy for patients with early active rheumatoid arthritis:clinical efficacy, disease-modifying properties, and side effects:a randomized, double-blind, placebo-controlled clinical trial[J]. Ann Intern Med, 2002, 136(1): 1-12.
[3] Goekoop-Ruiterman YP, de Vries-Bouwstra JK, Allaart CF, et al. Comparison of treatment strategies in early rheumatoid arthritis: a randomized trial [J]. Ann Intern Med, 2007, 146(6): 406-415.
[4] Machold KP,Landewe R,Smolen JS, et al. The Stop Arthritis Very Early (SAVE)trial, an international multicentre, randomised, double-blind, placebo-control-led trial on glucocorticoids in very early arthritis[J].Ann Rheum Dis,2010,69(3): 495-502.
[5] Todoerti M, Scire CA, Boffini N, et al. Early disease control by low-dose prednisone comedication may affect the quality of remission in patients with early rheumatoid arthritis[J]. Ann NY Acad Sci,2010, 1193: 139-145.
[6] Ciconelli RM, Ferraz MB, Santos W, et al. Traducao para a lingua portuguesa e validacao do questionario generico de avaliacao de qualidade de vida SF-36 (Brasil SF-36)[J]. Rev Bras Reumatol, 1999, 39: 143-150.
[7] Choy EHS, Scott DL. Drug treatment of rheumatic diseases in the 1990s[J]. Drugs, 1997, 53(3): 337-348.
[8] Hansen M,Podenphant J,Florescu A,et al.A randomized trial of differentiated prednisolone treatment in active rheumatoid arthritis:clinical benefits and skeletal side effects[J].Ann Rheum Dis,1999,58(11):713-718.
[9] Durez P, Nzeusseu Toukap A, Lauwerys BR, et al. A randomised comparative study of the short term clinical and biological effects of intravenous pulse methylprednisolone and infliximab in patients with active rheumatoid arthritis despite methotrexate treatment[J]. Ann Rheum Dis, 2004,63(9): 1069-1074.
[10] 李征寒,吴东红,王丽娟. 联合小剂量糖皮质激素治疗类风湿关节炎临床研究[J]. 中国现代药物应用,2009, 7(13):132-133.
[11] 徐胜前,邵宜波,徐建华,等. 类风湿关节炎患者骨密度变化的临床研究[J]. 临床内科杂志, 2004, 21(11): 763-765.
[12] Vosse D, de Vlam K. Osteoporosis in rheumatoid arthritis and ankylosing spondylitis[J]. Clin Exp Rheumatol, 2009, 27(4): S62-S67.
[13] 何伟珍,李剑松,李博, 等. 绝经前女性风湿病患者骨密度变化影响因素分析[J].实用医学杂志,2009,25(7):394-396.
[14] 张江林. 类风湿关节炎的骨质疏松研究进展[J]. 中华风湿病学杂志, 2008, 8(3): 503-505.
[15] Reid IR, Grey AB. Corticosteroid osteoporosis[J]. Bailliere's Clin Rheumatol, 1993, 7(7): 573-587.
[16] Baltzan MA, Suissa S, Bauer DC, et al. Hip fractures attributable to corticosteroid use[J]. Lancet, 1999, 353(9161): 1327.
[17] Wang JJ,Hu B,Kong LT,et al.Native,oxidized lipoprotein(a) and 1ipoprotein(a) immune complex in patients with active and inactive rheumatoid arthritis:Plasma concentrations and relationship to inflammation[J]. Clin Chim Acta,2008,390(1/2):67-71.
[18] 胡兵,汪俊军,张春妮,等.类风湿关节炎患者丙二醛修饰低密度脂蛋白及低密度脂蛋白循环免疫复合物水平分析[J].中国动脉硬化杂志,2008,16(7):296-298.
[19] Cannen GG,Joan MN,Josep V,et al.Conventional lipid profile and lipopr otein(a)concentrations in treated patiens with rheumatoid arthritis [J]. J Rheumtol,2009,36(121):1365-1370.
[20] Gomez CG,Nolla JM,Valverde J,et al.High HDL-cholesterol in women with rheumatoid arthritis on low-dose glucoeorticoid therapy[J].Eur J Ctin Invest,2008,38(33):686-692.
[21] 林小军,李伟念,何志翔,等. 小剂量糖皮质激素对类风湿关节炎患者血脂水平的影响[J]. 中国现代医生,2010, 7(6):11-12.
[22] Yong BP,Hyon,KC,Min YK,et al.Effects of antirheumtic therapy on serum lipid levels in patients with rheumatoid arthritis:a prospective study[J].Am J Med,2002,113(6):188-193.
[23] Somers EC,Thomas SL,Smeeth L,et al.Autoirmnune diseases co-occurring within individuals and within families:a systematic review[J]. Epidemiology, 2006,17(3):202-205.
[24] Liao KP,Gunnarsson M,Kllberg H,et al.Specific association of type 1 diabetes mellitus with anticyclic citrullinated peptide-positive rheumatoid arthritis[J].Arthritis Rheum,2009,60(6):653-657.
[25] Toms TE,Panoulas VF,John H,et al.Methotrexate therapy associates with reduced prevalence of the metabolic syndrome in rheumatoid arthritis patients over the age of 60-more than just an anti- inflammatory effect? A cross sectional study[J].Arthritis Res Ther,2009, 11(4):R110.
[26] Moreland LW, O'Dell JR. Glucocorticoids and rheumatoid arthritis: back to the future[J] ? Arthritis Rheum,2002, 46(10): 2552-2563